Comment on Y Combinator ups the ante with bio startups for 2015parentComments−car11yRegarding 23andMe, I'd reconsider that view.They are sitting on a treasure trove of medical and genetic data. And they have begun to monetize this data, which I believe was their endgame all along.More here: http://www.forbes.com/sites/matthewherper/2015/01/06/surpris...
Comments
Regarding 23andMe, I'd reconsider that view.
They are sitting on a treasure trove of medical and genetic data. And they have begun to monetize this data, which I believe was their endgame all along.
More here: http://www.forbes.com/sites/matthewherper/2015/01/06/surpris...